SMSbiotech Obtains Patent

SMSbiotech Obtains Patent

SMSbiotech obtained its patent on Small Mobile Stem Cells (SMS) and Uses Thereof.
Patent Number: US 10,041,037 B2


The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood and/or other sources and that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof...(Read More)



August 7, 2018
Copy link
This is some text inside of a div block.
Back to Lobby